Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01937117
Brief Title: Pertuzumab and Trastuzumab as Neoadjuvant Treatment in Patients With HER2-Positive Breast Cancer

First Submitted : September 3, 2013
First Submitted that Met QC Criteria : September 3, 2013
First Posted : September 9, 2013 (Estimate)

Results First Submitted : March 18, 2019
Results First Submitted that Met QC Criteria : April 10, 2019
Results First Posted : April 12, 2019

Last Update Submitted that Met QC Criteria : November 5, 2021
Last Update Posted : November 8, 2021